In The News Posted October 31, 2019 Share Posted October 31, 2019 COPENHAGEN, Denmark, Oct. 30, 2019 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) announced today that it is raising its Outlook for 2019. The improvement is due to better than expected sales of Envarsus XR® (tacrolimus extended-release tablets). Outlook 2019 Veloxis revises its... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.